Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24577154)

1.

Impact of delivery models on understanding genomic risk for type 2 diabetes.

Haga SB, Barry WT, Mills R, Svetkey L, Suchindran S, Willard HF, Ginsburg GS.

Public Health Genomics. 2014;17(2):95-104. doi: 10.1159/000358413. Epub 2014 Feb 27.

2.

Public trust in genomic risk assessment for type 2 diabetes mellitus.

Mills R, Barry W, Haga SB.

J Genet Couns. 2014 Jun;23(3):401-8. doi: 10.1007/s10897-013-9674-3. Epub 2013 Dec 3.

PMID:
24292896
3.

Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.

Cameron LD, Sherman KA, Marteau TM, Brown PM.

Health Psychol. 2009 May;28(3):307-16. doi: 10.1037/a0013947.

PMID:
19450036
4.

Information-seeking and sharing behavior following genomic testing for diabetes risk.

Mills R, Powell J, Barry W, Haga SB.

J Genet Couns. 2015 Feb;24(1):58-66. doi: 10.1007/s10897-014-9736-1. Epub 2014 Jun 14.

PMID:
24927802
5.
6.

Discussing race-related limitations of genomic testing for colon cancer risk: implications for education and counseling.

Butrick MN, Vanhusen L, Leventhal KG, Hooker GW, Nusbaum R, Peshkin BN, Salehizadeh Y, Pavlick J, Schwartz MD, Graves KD.

Soc Sci Med. 2014 Aug;114:26-37. doi: 10.1016/j.socscimed.2014.05.014. Epub 2014 May 15.

PMID:
24908172
7.

Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.

Cho AH, Killeya-Jones LA, O'Daniel JM, Kawamoto K, Gallagher P, Haga S, Lucas JE, Trujillo GM, Joy SV, Ginsburg GS.

BMC Health Serv Res. 2012 Jan 18;12:16. doi: 10.1186/1472-6963-12-16.

8.
10.

Perceptions of genetic counseling services in direct-to-consumer personal genomic testing.

Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS.

Clin Genet. 2013 Oct;84(4):335-9. doi: 10.1111/cge.12166. Epub 2013 May 13.

PMID:
23590221
11.

How should risk be communicated to children: a cross-sectional study comparing different formats of probability information.

Ulph F, Townsend E, Glazebrook C.

BMC Med Inform Decis Mak. 2009 Jun 5;9:26. doi: 10.1186/1472-6947-9-26.

12.

Effect of communicating genetic and phenotypic risk for type 2 diabetes in combination with lifestyle advice on objectively measured physical activity: protocol of a randomised controlled trial.

Godino JG, van Sluijs EM, Marteau TM, Sutton S, Sharp SJ, Griffin SJ.

BMC Public Health. 2012 Jun 18;12:444. doi: 10.1186/1471-2458-12-444.

13.

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM.

Pediatrics. 2001 Apr;107(4):699-705.

PMID:
11335747
14.

Public knowledge of and attitudes toward genetics and genetic testing.

Haga SB, Barry WT, Mills R, Ginsburg GS, Svetkey L, Sullivan J, Willard HF.

Genet Test Mol Biomarkers. 2013 Apr;17(4):327-35. doi: 10.1089/gtmb.2012.0350. Epub 2013 Feb 13.

15.

A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.

Albada A, van Dulmen S, Lindhout D, Bensing JM, Ausems MG.

Fam Cancer. 2012 Mar;11(1):85-95. doi: 10.1007/s10689-011-9479-1.

PMID:
21901499
16.

The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.

Eijzenga W, Aaronson NK, Kluijt I, Sidharta GN, Hahn DE, Ausems MG, Bleiker EM.

BMC Cancer. 2014 Jan 15;14:26. doi: 10.1186/1471-2407-14-26.

17.

Communication strategies for enhancing understanding of the behavioral implications of genetic and biomarker tests for disease risk: the role of coherence.

Cameron LD, Marteau TM, Brown PM, Klein WM, Sherman KA.

J Behav Med. 2012 Jun;35(3):286-98. doi: 10.1007/s10865-011-9361-5. Epub 2011 Jun 23.

PMID:
21698440
18.

Examining the impact of genetic testing for type 2 diabetes on health behaviors: study protocol for a randomized controlled trial.

Voils CI, Coffman CJ, Edelman D, Maciejewski ML, Grubber JM, Sadeghpour A, Cho A, McKenzie J, Blanpain F, Scheuner M, Sandelowski M, Gallagher MP, Ginsburg GS, Yancy WS Jr.

Trials. 2012 Aug 1;13:121. doi: 10.1186/1745-6215-13-121.

19.

Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.

Bloss CS, Schork NJ, Topol EJ.

J Med Genet. 2014 Feb;51(2):83-9. doi: 10.1136/jmedgenet-2013-101909. Epub 2013 Dec 16.

PMID:
24343916
20.

Genetic literacy and patient perceptions of IBD testing utility and disease control: a randomized vignette study of genetic testing.

Hooker GW, Peay H, Erby L, Bayless T, Biesecker BB, Roter DL.

Inflamm Bowel Dis. 2014 May;20(5):901-8. doi: 10.1097/MIB.0000000000000021.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk